Definitions of metabolic health andrisk of future type 2 diabetes in bmi categories: A systematic review and network Meta-analysis

Diabetes Care

Volumn 38, Issue 11, 2015, Pages 2177-2187

  Lotta, Luca A ^a   Abbasi, Ali ^a,b   Sharp, Stephen J ^a   Sahlqvist, Anna Stina ^c   Waterworth, Dawn ^d   Brosnan, Julia M ^e   Scott, Robert A ^a   Langenberg, Claudia ^a   Wareham, Nicholas J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c GLAXOSMITHKLINE   (United Kingdom)

^d GLAXOSMITHKLINE   (United States)

^e Cardiovascular and Metabolic Research Unit   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MASS; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HIGH RISK POPULATION; HUMAN; INCIDENCE; LEAN BODY WEIGHT; MEDICAL RESEARCH; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREDICTION; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; OVERWEIGHT; PROGNOSIS; RISK;

BODY MASS INDEX; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; HUMANS; OBESITY; OVERWEIGHT; PROGNOSIS; RISK;

EID: 84962339031     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc15-1218     Document Type: Article

References (39)

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-1428.
2. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-787.
3. Grundy SM, Hansen B, Smith SC Jr, Cleeman JI, Kahn RA; American Heart Association; National Heart, Lung, and Blood Institute; American Diabetes Association. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Arterioscler Thromb Vasc Biol 2004;24:e19-e24.
4. Stefan N, Häring HU, Hu FB, Schulze MB. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol 2013;1:152-162.
5. Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? A systematic review andmeta-analysis. Ann Intern Med 2013;159:758-769.
6. Bell JA, Kivimaki M, Hamer M. Metabolically healthy obesity and risk of incident type 2 diabetes: A meta-analysis of prospective cohort studies. Obes Rev 2014;15:504-515.
7. Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008;168:1617-1624.
8. Karelis AD, Brochu M, Rabasa-Lhoret R. Canwe identify metabolically healthy but obese individuals (MHO)? Diabetes Metab 2004;30:569-572.
9. van Vliet-Ostaptchouk JV, Nuotio ML, Slagter SN, et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: A collaborative analysis of ten large cohort studies. BMC Endocr Disord 2014;14:9.
10. Shin JA, Lee JH, Lim SY, et al. Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness. J Diabetes Investig 2013;4:334-343.
11. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700.
12. World Health Organization. Obesity and Overweight. Fact Sheet No. 311. Geneva, World Health Org., 2014.
13. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-163.
14. Hinnouho GM, Czernichow S, Dugravot A, et al. Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: The Whitehall II cohort study. Eur Heart J 2015; 36:551-559.
15. Soriguer F, Gutiérrez-Repiso C, Rubio Martín E, et al. Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study. J Clin Endocrinol Metab 2013;98: 2318-2325.
16. Sung KC, Jeong WS, Wild SH, Byrne CD. Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes. Diabetes Care 2012;35:717-722.
17. Hadaegh F, Bozorgmanesh M, Safarkhani M, Khalili D, Azizi F. "Predictability of body mass index for diabetes: Affected by the presence of metabolic syndrome?" BMC Public Health 2011; 11:383.
18. Meigs JB, Wilson PW, Fox CS, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006;91:2906-2912.
19. Arnlöv J, Sundström J, Ingelsson E, Lind L. Impact of BMI and the metabolic syndrome on the risk of diabetes in middle-aged men. Diabetes Care 2011;34:61-65.
20. Appleton SL, Seaborn CJ, Visvanathan R, et al.; North West Adelaide Health Study Team. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: A cohort study. Diabetes Care 2013;36: 2388-2394.
21. Kim CH, Kim HK, Bae SJ, Kim EH, Park JY. Independent impact of body mass index and metabolic syndrome on the risk of type 2 diabetes in Koreans. Metab Syndr Relat Disord 2012; 10:321-325.
22. Bo S, Musso G, Gambino R, et al. Prognostic implications for insulin-sensitive and insulinresistant normal-weight and obese individuals from a population-based cohort. Am J Clin Nutr 2012;96:962-969.
23. Aung K, Lorenzo C, Hinojosa MA, Haffner SM. Risk of developing diabetes and cardiovascular disease inmetabolically unhealthy normal-weight andmetabolically healthy obese individuals. J Clin Endocrinol Metab 2014;99:462-468.
24. Twig G, Afek A, Derazne E, et al. Diabetes risk among overweight and obese metabolically healthy young adults. Diabetes Care 2014;37: 2989-2995.
25. Jung HS, Chang Y, Eun Yun K, et al. Impact of body mass index, metabolic health and weight change on incident diabetes in a Korean population. Obesity (Silver Spring) 2014;22:1880- 1887.
26. Heianza Y, Kato K, Kodama S, et al. Stability and changes in metabolically healthy overweight or obesity and risk of future diabetes: Niigata wellness study. Obesity (Silver Spring) 2014;22:2420-2425.
27. Heianza Y, Arase Y, Tsuji H, et al. Metabolically healthy obesity, presence or absence of fatty liver, and risk of type 2 diabetes in Japanese individuals: Toranomon Hospital Health Management Center Study 20 (TOPICS 20). J Clin Endocrinol Metab 2014;99:2952-2960.
28. Rhee EJ, Lee MK, Kim JD, et al. Metabolic health is a more important determinant for diabetes development than simple obesity: A 4-year retrospective longitudinal study. PLoS One 2014;9:e98369.
29. Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol 1997;50: 683-691.
30. White IR, Barrett JK, Jackson D, Higgins JP. Consistency and inconsistency in network metaanalysis: model estimation using multivariate meta-regression. Res Synth Methods 2012;3: 111-125.
31. Langenberg C, Sharp S, Forouhi NG, et al.; InterAct Consortium. Design and cohort description of the InterAct Project: An examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia 2011;54:2272-2282.
32. Harbord RM, Whiting P. metandi: metaanalysis of diagnostic accuracy using hierarchical logistic regression. Stata J 2009;9: 211-229.
33. Harris RJ, Bradburn MJ, Deeks JJ, Harbord RM, Altman DG, Sterne JAC. metan: fixed- And random- effects meta-analysis. Stata J 2008;8:3-28.
34. Thomas A, O'Hara B, Ligges U, Sturtz S. Making BUGS Open. R News 2006;6:12-17.
35. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421.
36. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and betacell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
37. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009;301:2129-2140.
38. Lear SA, Humphries KH, Kohli S, Chockalingam A, Frohlich JJ, Birmingham CL. Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). Am J Clin Nutr 2007;86:353-359.
39. Tirosh A, Shai I, Tekes-Manova D, et al.; Israeli Diabetes Research Group. Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 2005;353:1454- 1462.